These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 7606349

  • 1. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils.
    Talpain E, Armstrong RA, Coleman RA, Vardey CJ.
    Br J Pharmacol; 1995 Apr; 114(7):1459-65. PubMed ID: 7606349
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
    Armstrong RA.
    Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [Abstract] [Full Text] [Related]

  • 4. Characterization of prostanoid receptors on rat neutrophils.
    Wise H, Jones RL.
    Br J Pharmacol; 1994 Oct; 113(2):581-7. PubMed ID: 7834211
    [Abstract] [Full Text] [Related]

  • 5. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
    Zeng L, An S, Goetzl EJ.
    J Biol Chem; 1996 Nov 01; 271(44):27744-50. PubMed ID: 8910368
    [Abstract] [Full Text] [Related]

  • 6. Migration of neutrophils from blood to tissue: alteration of modulatory effects of prostanoid on superoxide generation in rabbits and humans.
    Kanamori Y, Niwa M, Kohno K, Al-Essa LY, Matsuno H, Kozawa O, Uematsu T.
    Life Sci; 1997 Nov 01; 60(16):1407-17. PubMed ID: 9096262
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the inhibitory prostanoid receptors on human neutrophils.
    Wheeldon A, Vardey CJ.
    Br J Pharmacol; 1993 Apr 01; 108(4):1051-4. PubMed ID: 8387383
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS, Jones RL.
    Br J Pharmacol; 1993 Feb 01; 108(2):363-9. PubMed ID: 8448586
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
    Teixeira MM, al-Rashed S, Rossi AG, Hellewell PG.
    Br J Pharmacol; 1997 May 01; 121(1):77-82. PubMed ID: 9146890
    [Abstract] [Full Text] [Related]

  • 10. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
    Zeng L, An S, Goetzl EJ.
    Biochemistry; 1996 Jun 04; 35(22):7159-64. PubMed ID: 8679543
    [Abstract] [Full Text] [Related]

  • 11. EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells.
    Takahashi S, Takeuchi K, Okabe S.
    Biochem Pharmacol; 1999 Dec 15; 58(12):1997-2002. PubMed ID: 10591156
    [Abstract] [Full Text] [Related]

  • 12. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
    Lawrence RA, Jones RL.
    Br J Pharmacol; 1992 Apr 15; 105(4):817-24. PubMed ID: 1324050
    [Abstract] [Full Text] [Related]

  • 13. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
    Turner NC, Wood LJ, Burns FM, Gueremy T, Souness JE.
    Br J Pharmacol; 1993 Apr 15; 108(4):876-83. PubMed ID: 8387385
    [Abstract] [Full Text] [Related]

  • 14. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
    Qian YM, Jones RL, Chan KM, Stock AI, Ho JK.
    Br J Pharmacol; 1994 Oct 15; 113(2):369-74. PubMed ID: 7834185
    [Abstract] [Full Text] [Related]

  • 15. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
    Clarke DL, Belvisi MG, Catley MC, Yacoub MH, Newton R, Giembycz MA.
    Br J Pharmacol; 2004 Apr 15; 141(7):1141-50. PubMed ID: 15023863
    [Abstract] [Full Text] [Related]

  • 16. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.
    Exp Cell Res; 2003 Oct 01; 289(2):265-74. PubMed ID: 14499627
    [Abstract] [Full Text] [Related]

  • 17. Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation.
    Wise H.
    Prostaglandins Leukot Essent Fatty Acids; 1998 Jan 01; 58(1):77-84. PubMed ID: 9482170
    [Abstract] [Full Text] [Related]

  • 18. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P, Woodward DF, Armstrong RA.
    Br J Pharmacol; 1997 Nov 01; 122(6):1135-45. PubMed ID: 9401778
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.